Brodell RT. JAAD Game Changers: Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: A propensity score-matched cohort study. J Am Acad Dermatol 2023 Sep 22:S0190-9622(23)02851.
PMID: 37742838